Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.

There is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel...

Full description

Bibliographic Details
Main Authors: Pennington, K, Beasley, C, Dicker, P, Fagan, A, English, J, Pariante, C, Wait, R, Dunn, M, Cotter, DR
Format: Journal article
Language:English
Published: 2008
_version_ 1797057103367503872
author Pennington, K
Beasley, C
Dicker, P
Fagan, A
English, J
Pariante, C
Wait, R
Dunn, M
Cotter, DR
author_facet Pennington, K
Beasley, C
Dicker, P
Fagan, A
English, J
Pariante, C
Wait, R
Dunn, M
Cotter, DR
author_sort Pennington, K
collection OXFORD
description There is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel electrophoresis. Tissue samples were obtained from 35 individuals with schizophrenia, 35 with bipolar disorder and 35 controls. Eleven protein spots in schizophrenia and 48 in bipolar disorder were found to be differentially expressed (P<0.01) in comparison to controls, with 7 additional spots found to be altered in both diseases. Using mass spectrometry, 15 schizophrenia-associated proteins and 51 bipolar disorder-associated proteins were identified. The functional groups most affected included synaptic proteins (7 of the 15) in schizophrenia and metabolic or mitochondrial-associated proteins (25 of the 51) in bipolar disorder. Six of seven synaptic-associated proteins abnormally expressed in bipolar disorder were isoforms of the septin family, while two septin protein spots were also significantly differentially expressed in schizophrenia. This finding represented the largest number of abnormalities from one protein family. All septin protein spots were upregulated in disease in comparison to controls. This study provides further characterization of the synaptic pathology present in schizophrenia and of the metabolic dysfunction observed in bipolar disorder. In addition, our study has provided strong evidence implicating the septin protein family of proteins in psychiatric disorders for the first time.
first_indexed 2024-03-06T19:31:31Z
format Journal article
id oxford-uuid:1d9d96b8-6cf0-4143-a4d3-e2812c8d72ac
institution University of Oxford
language English
last_indexed 2024-03-06T19:31:31Z
publishDate 2008
record_format dspace
spelling oxford-uuid:1d9d96b8-6cf0-4143-a4d3-e2812c8d72ac2022-03-26T11:11:59ZProminent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1d9d96b8-6cf0-4143-a4d3-e2812c8d72acEnglishSymplectic Elements at Oxford2008Pennington, KBeasley, CDicker, PFagan, AEnglish, JPariante, CWait, RDunn, MCotter, DRThere is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel electrophoresis. Tissue samples were obtained from 35 individuals with schizophrenia, 35 with bipolar disorder and 35 controls. Eleven protein spots in schizophrenia and 48 in bipolar disorder were found to be differentially expressed (P<0.01) in comparison to controls, with 7 additional spots found to be altered in both diseases. Using mass spectrometry, 15 schizophrenia-associated proteins and 51 bipolar disorder-associated proteins were identified. The functional groups most affected included synaptic proteins (7 of the 15) in schizophrenia and metabolic or mitochondrial-associated proteins (25 of the 51) in bipolar disorder. Six of seven synaptic-associated proteins abnormally expressed in bipolar disorder were isoforms of the septin family, while two septin protein spots were also significantly differentially expressed in schizophrenia. This finding represented the largest number of abnormalities from one protein family. All septin protein spots were upregulated in disease in comparison to controls. This study provides further characterization of the synaptic pathology present in schizophrenia and of the metabolic dysfunction observed in bipolar disorder. In addition, our study has provided strong evidence implicating the septin protein family of proteins in psychiatric disorders for the first time.
spellingShingle Pennington, K
Beasley, C
Dicker, P
Fagan, A
English, J
Pariante, C
Wait, R
Dunn, M
Cotter, DR
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title_full Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title_fullStr Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title_full_unstemmed Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title_short Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
title_sort prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
work_keys_str_mv AT penningtonk prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT beasleyc prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT dickerp prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT fagana prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT englishj prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT pariantec prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT waitr prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT dunnm prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder
AT cotterdr prominentsynapticandmetabolicabnormalitiesrevealedbyproteomicanalysisofthedorsolateralprefrontalcortexinschizophreniaandbipolardisorder